Literature DB >> 16148593

Primary and secondary prevention of chronic kidney disease.

Kambiz Zandi-Nejad1, Barry M Brenner.   

Abstract

The incidence and prevalence of chronic kidney disease (CKD) is on the rise worldwide. End-stage renal disease (ESRD) is the most advanced form of CKD, requiring some form of renal replacement therapy to ensure survival. Interventions to prevent or slow the progression of CKD, irrespective of the original cause, are thus of significant importance. The most effective of these interventions is based on the inhibition of the renin-angiotensin system (RAS) and is the main focus of this review.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148593     DOI: 10.1097/01.hjh.0000183635.00606.5b

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  3 in total

1.  Should we employ combination ACEI and ARB therapy in primary hypertension?

Authors:  Robert M Carey
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

2.  The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease.

Authors:  Susan L Furth; Stephen R Cole; Jeffrey J Fadrowski; Arlene Gerson; Christopher B Pierce; Manju Chandra; Robert Weiss; Frederick Kaskel
Journal:  Pediatr Nephrol       Date:  2006-11-21       Impact factor: 3.714

3.  CKD and hypertension during long-term follow-up in children and adolescents previously treated with extracorporeal membrane oxygenation.

Authors:  Alexandra J M Zwiers; Hanneke IJsselstijn; Joost van Rosmalen; Saskia J Gischler; Saskia N de Wildt; Dick Tibboel; Karlien Cransberg
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-02       Impact factor: 8.237

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.